FDA Inspection 1195333 - LXR Biotech - January 20, 2023

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore LXR Biotech

Record Details

This FDA Inspection record concerns LXR Biotech, with an inspection on January 20, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: LXR Biotech
Inspection Date: January 20, 2023
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · 89adf9b7-fbd9-495f-9e44-68b8b21a4a37

Violation Codes7

21 CFR 211.100(a)21 CFR 211.13021 CFR 211.160(b)21 CFR 211.18821 CFR 211.22(a)21 CFR 211.22(d)21 CFR 211.84(b)

Full citation text and observation details available on the Dashboard.